A. Corlateanu (Chisihau, Republic of Moldova), R. Cherneva (Sofia, Bulgaria)
Eosinophilic asthma phenotypes in the UK population
M. Kerkhof (Singapore, Singapore), T. Tran (Gaithersburg, United States of America), J. Zangrilli (Gaithersburg, United States of America), V. Carter (Singapore, Singapore), D. Price (Singapore, Singapore)
|   |
Evaluation of Serum Chitotriozidase Activity and C - reactive protein and Albumin Ratio in Cystic Fibrosis and Bronchopulmonary Dysplasia
F. Çobanoglu (Ankara, Turkey), E. Kelestemur (Ankara, Turkey), O. Ceylan Dogan (Ankara, Turkey), T. Eminoglu (Ankara, Turkey)
| |
Dual-energy CT-derived microvascular perfused blood volume and lung function and %emphysema in the MESA Lung study
E. Hermann (New York, United States of America), G. Hiura (New York, United States of America), E. Hoffman (Iowa City, United States of America), A. Motahari (Iowa City, United States of America), J. Guo (Iowa City, United States of America), N. Allen (Evanston, United States of America), A. Bertoni (Winston-Salem, United States of America), D. Bluemke (Madison, United States of America), J. Pankow (Minneapolis, United States of America), E. Michos (Baltimore, United States of America), K. Hinckley Stukovsky (Seattle, United States of America), K. Watson (Los Angeles, United States of America), G. Barr (New York, United States of America)
| |
Serum testosterone and asthma outcomes in two large population-based studies
Y. Han (Pittsburgh, United States of America), Q. Yan (Pittsburgh, United States of America), G. Yang (Pittsburgh, United States of America), W. Chen (Pittsburgh, United States of America), E. Forno (Pittsburgh, United States of America), J. Celedón (Pittsburgh, United States of America)
| |
The mediating role of C-reactive protein (CRP) and insulin resistance in the association of mid-childhood fat mass and airflow limitation at 15 years
G. Peralta (Barcelona, Spain), R. Granell (Bristol, United Kingdom), A. Bédard (Barcelona, Spain), L. Howe (Bristol, United Kingdom), A. Carsin (Barcelona, Spain), D. Jarvis (London, United Kingdom), J. Garcia-Aymerich (Barcelona, Spain)
| |
Somatotypes trajectories during adulthood and its association with COPD phenotypes
M. Divo (Boston, United States of America), M. Marin Oto (Pamplona, Spain), C. Casanova (Tenerife, Spain), C. Cabrera Lopez (Gran canaria, Spain), J. De-Torres (Pamplona, Spain), J. Marin (Zaragoza, Spain), C. Hersh (Boston, United States of America), A. Ezponda (Pamplona, Spain), V. Pinto-Plata (Springfield, United States of America), F. Polverino (Tucson, United States of America), J. Ross (Boston, United States of America), D. Demeo (Boston, United States of America), G. Bastarrika (Pamplona, Spain), E. Silverman (Boston, United States of America), B. Celli (Boston, United States of America)
| |
Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment.
A. Ofenheimer (Wien, Austria), R. Breyer-Kohansal (Wien, Austria), S. Hartl (Wien, Austria), O. Burghuber (Wien, Austria), J. Altziebler (Wien, Austria), A. Schrott (Wien, Austria), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), J. Harreiter (Wien, Austria), A. Kautzky-Willer (Wien, Austria), M. Breyer (Wien, Austria)
| |
Lung function in adult offspring as associated with their father's overweight in childhood/puberty
M. Lønnebotn (Bergen, Norway), L. Calciano (Verona, Italy), S. Accordini (Verona, Italy), B. Benediktsdóttir (Reykjavik, Iceland), L. Bråbäck (Umeå, Sweden), M. Holm (Gothenburg, Sweden), N. Jogi (Bergen, Norway), A. Johannessen (Bergen, Norway), A. Malinovschi (Uppsala, Sweden), A. Pereira-Vega (Huelva, Spain), V. Schlünssen (Aarhus, Denmark), S. Dharmage (Melbourne, Australia), F. Gómez Real (Bergen, Norway), C. Svanes (Bergen, Norway)
| |
Systemic proteolytic markers are increased and associate with comorbidities in individuals with COPD and restrictive spirometric pattern
U. Nilsson (Umeå, Sweden), V. Pleiborn (Umeå, Sweden), R. Linder (Umeå, Sweden), H. Backman (Umeå, Sweden), A. Behndig (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden)
| |
Guilty pleasures and the healthy lung microbiota
S. Tangedal (Bergen, Norway), R. Nielsen (Bergen, Norway), M. Aanerud (Bergen, Norway), G. Husebø (Bergen, Norway), H. Wiker (Bergen, Norway), P. Bakke (Bergen, Norway), T. Eagan (Bergen, Norway)
| |
Radiologic assed rhinosinusitis, eosinophils and lung function in a population-based cohort of elderly, a comparison of subjects with and without asthma
E. de Roos (Rotterdam, Netherlands), J. Arinze (Rotterdam, Netherlands), L. Lahousse (Rotterdam, Netherlands), G. Brusselle (Ghent, Belgium)
| |
Experience of measuring nasal nitric oxide (nNO) in a National Primary Ciliary Dyskinesia (PCD) Centre (2006-20)
A. Harris (Southampton (Hampshire), United Kingdom), H. Phan (Southampton (Hampshire), United Kingdom), F. Borca (Southampton (Hampshire), United Kingdom), S. Packham (Southampton (Hampshire), United Kingdom), A. Friend (Southampton (Hampshire), United Kingdom), H. Wilkins (Southampton (Hampshire), United Kingdom), A. Glen (Southampton (Hampshire), United Kingdom), W. Walker (Southampton (Hampshire), United Kingdom), J. Lucas (Southampton (Hampshire), United Kingdom)
| |
The impact of sensitization to Staphylococcus aureus–derived enterotoxins on allergic and respiratory disorders
M. Olivieri (Verona (VR), Italy), N. Murgia (Perugia (PG), Italy), N. Antonucci (Verona (VR), Italy), P. Marchetti (Verona (VR), Italy), G. Spiteri (Verona (VR), Italy), M. Ferrari (Verona (VR), Italy), G. Verlato (Verona (VR), Italy)
| |
Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries
C. Rebordosa (Barcelona, Spain), A. Rubino (Cambridge, United Kingdom), A. Witzleb (Bremen, Germany), M. Olesen (Odense, Denmark), E. Plana (Barcelona, Spain), J. Aguado (Barcelona, Spain), N. Saigi (Barcelona, Spain), S. Daoud (Gaithersburg, Maryland, United States of America), A. Lei (Barcelona, Spain), S. Perez-Gutthann (Barcelona, Spain), T. Schink (Bremen, Germany), N. Kristiansen (Odense, Denmark), A. Pottegard (Odense, Denmark), E. Rivero-Ferrer (Barcelona, Spain)
| |
Serum anti-Ascaris IgG concentration and lung function in a multi-centre Northern-European cohort
N. Jogi (Bergen, Norway), R. Jacobsen Bertelsen (Bergen, Norway), T. Storaas (Bergen, Norway), V. Schlu¨nssen (Aarhus, Denmark), W. Horsnell (Cape Town, South Africa), C. Svanes (Bergen, Norway)
| |
Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
A. Gracheva (Moscow, Russian Federation), A. Panova (Moscow, Russian Federation), A. Vinokurov (Moscow, Russian Federation), G. Pay (Moscow, Russian Federation), O. Lovacheva (Moscow, Russian Federation), G. Kaminskiy (Moscow, Russian Federation), I. Vasilyeva (Moscow, Russian Federation)
| |
hsCRP is associated with 10-year mortality in COPD.
E. Lagrange (Umeå, Sweden), U. Nilsson (Umeå, Sweden), C. Stridsman (Umeå, Sweden), H. Backman (Umeå, Sweden), L. Hedman (Umeå, Sweden), A. Lindberg (Umeå, Sweden), A. Blomberg (Umeå, Sweden)
| |
Presence of serum antibodies anti-benzo(a)pyrenediol epoxide (BPDE-DNA) and tobacco smoking as predictors of respiratory outcomes
F. Pistelli (Pisa , Italy), S. Maio (Pisa , Italy), S. Baldacci (Pisa, Italy), L. Carrozzi (Pisa, Italy), G. Viegi (Palermo, Italy)
| |
Associations between oscillometry parameters and respiratory outcomes in young children: the SEPAGES cohort
V. Siroux (Grenoble, France), A. Boudier (Grenoble, France), S. Lyon-Caen (Grenoble, France), J. Quentin (Grenoble, France), Y. Gioria (Grenoble, France), R. Slama (Grenoble, France), I. Pin (Grenoble, France), S. Bayat (Grenoble, France)
| |
Prevalence of Chlamydia pneumoniae antibodies in Southern Hungary
D. Paróczai (Deszk, Hungary), D. Kókai (Szeged, Hungary), Á. Ulbert (Szeged, Hungary), G. Terhes (Szeged, Hungary), K. Burián (Szeged, Hungary)
| |